Chester County News and Community Website
PLYMOUTH MEETING, PA — Every cancer center responding to a National Comprehensive Cancer Network survey reported at least one anti-cancer drug shortage in late August, extending a supply problem that …
Cancer Drug Shortages Persist at Major U.S. Centers Read More
PHILADELPHIA, PA — Fore Biotherapeutics will continue its FORTE study of plixorafenib as planned after an independent monitoring committee cleared the first interim efficacy analysis of its BRAF fusion cohort, …
Fore Bio Clears Interim Review in BRAF Fusion Cancer Study Read More
KING OF PRUSSIA, PA — SEED Therapeutics has advanced its experimental cancer treatment into a third dosing cohort in a first-in-human clinical trial, establishing early evidence that the drug degrades …
SEED Advances Cancer Drug as Human Trial Reaches Third Cohort Read More
WILMINGTON, DE — AstraZeneca’s experimental antibody-drug conjugate sonesitatug vedotin improved overall survival in a Phase III trial of previously treated CLDN18.2-positive advanced gastric and related cancers, potentially broadening targeted treatment …
AstraZeneca Drug Extends Survival in Advanced Gastric Cancer Read More
WILMINGTON, DE — Incyte Corp. (Nasdaq: INCY) will present early clinical data on two cancer treatments that have advanced into Phase 3 testing at the ESMO Congress in Madrid this …
Incyte Advances Two Cancer Drugs as ESMO Congress Nears Read More
CONSHOHOCKEN, PA — Cencora has entered an agreement with Kite, a unit of Gilead Sciences, to distribute two FDA-approved CAR T-cell cancer therapies across a growing network of treatment centers, …
Cencora, Kite Expand CAR-T Distribution Network as Access Grows Read More
WILMINGTON, DE — AstraZeneca has secured U.S. regulatory approval for IMFINZI (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) therapy for adults with previously untreated high-risk non-muscle-invasive bladder cancer, expanding the …
AstraZeneca Wins FDA Approval for IMFINZI in Early Bladder Cancer Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network has launched a free weekly email service that alerts users to changes in its widely used cancer treatment guidelines, expanding access …
NCCN Launches Weekly Cancer Guideline Alerts for Clinicians Read More WILMINGTON, DE — AstraZeneca said new Phase III cancer and rare disease data presented at the American Society of Clinical Oncology annual meeting could strengthen the company’s position in several …
AstraZeneca Highlights Late-Stage Cancer, Rare Disease Data at ASCO Read More WILMINGTON, DE — AstraZeneca (LSE/STO/NYSE: AZN) reported positive Phase III trial results showing its immunotherapy IMFINZI combined with enfortumab vedotin improved survival outcomes for certain muscle-invasive bladder cancer patients unable …
AstraZeneca Trial Extends Survival in Bladder Cancer Study Read More